| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.02T | 996.35B | 941.17B | 868.69B | 853.06B |
| Gross Profit | 407.53B | 398.06B | 354.85B | 318.99B | 313.61B |
| EBITDA | 186.30B | 182.67B | 164.01B | 153.11B | 128.23B |
| Net Income | 103.59B | 130.11B | 80.01B | 72.78B | 62.25B |
Balance Sheet | |||||
| Total Assets | 1.90T | 1.81T | 1.77T | 1.75T | 1.70T |
| Cash, Cash Equivalents and Short-Term Investments | 357.59B | 464.77B | 602.17B | 557.62B | 491.06B |
| Total Debt | 259.02B | 248.49B | 205.69B | 195.63B | 176.85B |
| Total Liabilities | 780.37B | 715.21B | 652.46B | 630.33B | 614.25B |
| Stockholders Equity | 1.06T | 1.01T | 986.89B | 990.03B | 949.90B |
Cash Flow | |||||
| Free Cash Flow | -50.72B | 78.16B | 150.82B | 165.52B | 87.95B |
| Operating Cash Flow | 76.21B | 164.82B | 184.01B | 199.90B | 140.39B |
| Investing Cash Flow | -67.34B | -206.61B | -26.27B | -137.20B | -190.54B |
| Financing Cash Flow | -20.57B | -57.12B | -104.81B | -64.07B | -68.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $116.09B | 8.10 | 24.04% | ― | 11.69% | -1.85% | |
70 Outperform | $2.60T | 28.22 | 23.34% | ― | 14.22% | 35.55% | |
70 Outperform | $80.59B | 41.97 | 29.58% | ― | 42.11% | -6.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | $39.40B | 19.23 | 6.15% | 3.37% | 12.13% | -67.45% | |
54 Neutral | $263.06B | 18.10 | 10.00% | 1.31% | 4.44% | -16.38% | |
54 Neutral | $30.19B | -186.04 | -3.67% | ― | 13.10% | -163.64% |